Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,897Revenue $M0Net Margin (%)0Z-Score
Enterprise Value $M4,891EPS $0Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %2.0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M0ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with XLV

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
XLVKen Fisher 2014-06-30 Add0.01%$55.71 - $61.23
($58.7)
$ 72.2423%Add 34.36%226,412
XLVJohn Burbank 2014-03-31 Buy 0.03%$54.86 - $60.12
($57.55)
$ 72.2426%New holding, 17173 sh.17,173
XLVGeorge Soros 2012-09-30 Sold Out -0.03%$37.27 - $40.3
($38.73)
$ 72.2486%Sold Out0
XLVGeorge Soros 2012-06-30 Buy 0.03%$35.52 - $37.87
($36.91)
$ 72.2496%New holding, 50000 sh.50,000
XLVKen Fisher 2012-06-30 Add$35.52 - $37.87
($36.91)
$ 72.2496%Add 53.52%119,754
XLVKen Fisher 2011-06-30 Buy 0.01%$33.28 - $36.42
($34.99)
$ 72.24106%New holding, 86997 sh.86,997
XLVGeorge Soros 2011-03-31 Sold Out $31.5 - $33.18
($32.33)
$ 72.24123%Sold Out0
XLVGeorge Soros 2010-12-31 Reduce-0.15%$30.19 - $31.78
($31.13)
$ 72.24132%Reduce -93.88%34,153
XLVGeorge Soros 2010-09-30 Buy 0.25%$28.03 - $30.68
($29.2)
$ 72.24147%New holding, 558053 sh.558,053
XLVGeorge Soros 2010-06-30 Sold Out $28.38 - $32.31
($30.13)
$ 72.24140%Sold Out0
XLVGeorge Soros 2010-03-31 Reduce$30.68 - $33
($31.72)
$ 72.24128%Reduce -43.59%6,600
XLVGeorge Soros 2009-12-31 Buy 0.01%$28.07 - $31.62
($30.04)
$ 72.24140%New holding, 11700 sh.11,700
XLVBill Gates 2009-06-30 Sold Out -4.19%$23.76 - $26.53
($25.04)
$ 72.24188%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XLV is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
XLV Ken Fisher 2014-12-31247,355 0.04+5.35%
Premium Most recent portfolio changes are included for Premium Members only!


XLV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lavallée, Jean-Raymond10% Security Holder 2015-02-27Buy135,000$0.172140view
Lavallée, Jean-Raymond10% Security Holder 2015-02-27Buy19,000$0.172140view
Lavallée, Jean-SébastienDirector, Senior Officer 2015-02-27Buy215,000$0.172140view
Dumas, Paul AndrewDirector, Senior Officer 2015-02-26Buy120,000$0.06120300view
Legault, MarcSenior Officer 2015-02-26Sell1,235$40.5278.28view
Bestmann, MartinSenior Officer 2015-02-26Sell15,000$078.28view
Lavallée, Jean-SébastienDirector, Senior Officer 2015-02-26Buy18,000$0.172140view
Tognetti, John10% Security Holder 2015-02-26Buy13,000$0.1355469.23view
Jaguar Financial Corporation10% Security Holder 2015-02-26Buy47,500$0.1355469.23view
Disbrow, Robert10% Security Holder 2015-02-26Buy2,000,000$0.04180500view

Press Releases about XLV :

    Quarterly/Annual Reports about XLV:

      News about XLV:

      Articles On GuruFocus.com
      Build a “Whatever Happens” Portfolio – Now! Aug 15 2014 
      Are Earnings Important? These Days, Revenues Count for More! Mar 17 2014 


      More From Other Websites
      The week ahead: Buffett on Squawk Box Monday Feb 27 2015
      Increased Mergers and Acquistions Help, But Headwinds Persist Feb 27 2015
      Why should you invest in healthcare ETFs? Feb 27 2015
      Why antibiotics need innovation: Ezekiel Emanuel Feb 27 2015
      Health Care Stocks Flexing Their Muscle Feb 26 2015
      Nasdaq pursues 5K Feb 26 2015
      Global market check Feb 25 2015
      Humana’s income rises 21% year-over-year in 4th-quarter 2014 Feb 25 2015
      Ned Davis Research Looks Beyond the Plain-Vanilla ETF in Health Care Feb 25 2015
      Don't kid yourself: stocks are just as overvalued today as they were in 2000 Feb 24 2015
      Top Ranked Healthcare Service ETF in Focus: IHF - ETF News And Commentary Feb 24 2015
      Yes, Healthcare ETFs can Keep Rising Feb 24 2015
      Will there ever be another correction? Feb 24 2015
      Humana’s valuations tied to its reliance on Medicare Feb 24 2015
      And Stocks take the lead... Feb 24 2015
      Humana’s financial risk managed by capital requirements Feb 24 2015
      Humana spends most on hospital benefits Feb 24 2015
      Marketing, brand, and big pharma’s real consumer targets Feb 24 2015
      How Humana sells health plans on public and private exchanges Feb 24 2015
      Most Humana stakeholders are mutual funds or advisers Feb 24 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK